Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / UBX - Our First Take On Unity Biotechnology

UBX - Our First Take On Unity Biotechnology

Unity Biotechnology Inc.
  • Anti-aging concern Unity Biotechnology, Inc. saw its share price collapse after its lead candidate (UBX0101) flunked a Phase 2 study in August 2020.
  • The setback forced a restructuring with a pivot away from musculoskeletal targets and towards ophthalmologic and neurologic indications.
  • With one early-stage clinical asset, a greater than 100% rebound off its post-clinical-failure lows, and a cash runway into mid-2022, this busted IPO warranted additional investigation.
  • A full investment analysis follows below.

For further details see:

Our First Take On Unity Biotechnology
Stock Information
Company Name: Unity Biotechnology Inc.
Stock Symbol: UBX
Market: NASDAQ
Website: unitybiotechnology.com
Menu
UBX UBX Quote UBX Short UBX News UBX Articles UBX Message Board
Get UBX Alerts

News, Short Squeeze, Breakout and More Instantly...